The global Sleep Apnea Devices Industry is poised for remarkable growth, with a steady compound annual growth rate (CAGR) of 9.5% projected during the forecast period. According to the latest market analysis, the sector is currently valued at US$ 8.2 billion in 2023 and is anticipated to reach an impressive US$ 20.4 billion by 2033. …
Category Archives: Healthcare Trends
Organ Preservation Industry Set for Striking 6.4% CAGR, Expected to Exceed US$ 455 Million by 2032 | Finds FMI Study
By 2032, the Organ Preservation Industry will be worth US$ 455 million, expanding at a compound annual growth rate of 6.4%. Organ preservation is the act of conserving healthy donor organs so they can be transplanted into the bodies of recipients. Static cold storage (SCS), which stops toxic metabolites from destroying healthy tissue, helps to sustain normal …
Glaucoma Treatment Industry Set to Reach US$ 8 Billion by 2033, FMI Predicts 3.2% CAGR Growth | FMI
The global Glaucoma Treatment Industry holds a valuation of US$ 5.7 Billion by the end of the year 2022. During the forecast period of 2023 to 2033, the market is expected to grow at a CAGR of 3.2%, with a market value of around US$ 8.0 billion in 2033. The elderly population is more into getting infected …
Interventional Radiology Industry Set to Soar, Anticipated to Hit US$ 42.7 Billion by 2032 | Reveals FMI Report
The global Interventional Radiology Industry is anticipated to increase from US$ 24.9 Billion in 2021 to US$ 42.7 Billion market by 2032, growing at a CAGR of 5% during the forecast period, according to the exclusive analysis of Future Market Insights (FMI). There is an increasing need for cutting-edge treatment methods using scanners and X-ray vision technology …
Diabetic Shoes Industry Soars Towards US$ 16.0 Billion by 2033, Fueled by a Remarkable 6.4% CAGR | Reports FMI
Future Market Insights (FMI) employed a multidisciplinary methodology to concentrate on the growth and development of the Diabetic Shoes Industry during the pandemic era. The market for diabetic shoes is anticipated to reach US$ 8.6 billion in 2023 and US$ 16.0 billion by 2033, respectively. Over the projection year, it is expected that sales of diabetic …
Chromatography Software Industry Surges with a Projected US$ 3.2 Billion by 2033, Fueled by an Impressive 11.3% CAGR | FMI
The Chromatography Software Industry, which was worth US$ 1.1 billion in 2023, is predicted to grow to US$ 3.2 billion by 2033. Chromatography techniques are increasingly being used in a variety of disciplines, including the chemical and pharmaceutical industries, environmental testing laboratories, the food industry, and forensic science, which is expected to offer up new potential …
Pharmaceutical Drug Delivery Industry Targets a Striking 6.4% CAGR, Anticipating a US$3.5 Trillion Milestone by 2033 | FMI
The global Pharmaceutical Drug Delivery Industry is poised for substantial growth with a robust CAGR of 6.4% throughout the forecast period. In 2023, the market is currently valued at a significant US$ 1.9 trillion. Projections indicate that the pharmaceutical drug delivery market is on track to surge to an impressive US$ 3.5 trillion by the year 2033. …
Molecular Quality Controls Industry Set to Soar Beyond US$ 408 Million by 2033, Achieving a Remarkable 7.2% CAGR | FMI
According to the latest market research by FMI, the global Molecular Quality Controls Market is anticipated to reach US$ 204 million in value in 2023. Throughout the projected period, the market is anticipated to grow at a CAGR of 7.2%. The estimate is expected to surpass US$ 408 million by 2033. The global molecular quality controls …
Drug Eruptions Treatment Market Anticipates a Striking US$ 7.1 Billion Projection by 2033-FMI Study
In fiscal year 2023, the global Drug Eruptions Treatment Market revenue is expected to be worth US$ 3.89 billion, up from US$ 3.66 billion in fiscal year 2022. The global market is expected to grow at a 6.2% CAGR from 2023 to 2033, reaching US$ 7.1 billion by the end of that year. A drug rash is …
Donohue Syndrome Treatment Market Achieves a Pinnacle US$ 25 Billion Milestone by 2033-FMI Study
According to a recent FMI analysis, the global Donohue Syndrome Treatment Market Demand is expected to grow at a 4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 25 billion by the end of the assessment period. Donohue syndrome, also known as leprechaunism, is an extremely rare and severe genetic disorder …